首页 > 最新文献

Indian Journal of Medical Research最新文献

英文 中文
Experiences of women with endometriosis & their partners in India: Findings from a qualitative study. 印度子宫内膜异位症妇女及其伴侣的经历:一项定性研究的结果。
IF 2.5 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 DOI: 10.25259/IJMR_1338_2025
Preety R Rajbangshi, Sapna Desai, Rahul K Gajbhiye, Krina T Zondervan, Vanita Jain, Robyn Norton

Background & objectives Endometriosis, a chronic inflammatory condition, affects approximately 10 per cent of reproductive-age women in India. This study aimed to explore the experiences of women with endometriosis and their partners. Methods A qualitative exploratory study was conducted in two Indian States. In-depth interviews were conducted with 21 women (18-49 yr) with laparoscopically diagnosed endometriosis and 10 of their male partners. Interviews were conducted in local languages and English, with informed consent. Recordings were transcribed, coded, and analysed using Braun and Clarke's thematic analysis. Results The study revealed significant impacts of endometriosis on both women and men, including decreased quality of life, psychological effects, financial distress, strained intimate relationships and burden of infertility. Women experienced greater impacts, particularly in life opportunities and employment, social life and mental health. Delayed diagnosis and treatment exacerbated women's suffering, compromising their well-being and quality of life. Interpretation & conclusions This study emphasises the need for improved early diagnosis and treatment of endometriosis to mitigate its impact on women and their partners.

背景与目的子宫内膜异位症是一种慢性炎症,影响了印度大约10%的育龄妇女。本研究旨在探讨子宫内膜异位症女性及其伴侣的经历。方法在印度两个邦进行定性探索性研究。对21名经腹腔镜诊断为子宫内膜异位症的女性(18-49岁)及其10名男性伴侣进行了深入访谈。访谈在知情同意的情况下以当地语言和英语进行。录音被转录、编码,并使用Braun和Clarke的主题分析进行分析。结果研究显示,子宫内膜异位症对女性和男性都有显著影响,包括生活质量下降、心理影响、经济困难、亲密关系紧张和不孕负担。妇女受到的影响更大,特别是在生活机会和就业、社会生活和心理健康方面。延误的诊断和治疗加剧了妇女的痛苦,损害了她们的福祉和生活质量。本研究强调需要改进子宫内膜异位症的早期诊断和治疗,以减轻其对女性及其伴侣的影响。
{"title":"Experiences of women with endometriosis & their partners in India: Findings from a qualitative study.","authors":"Preety R Rajbangshi, Sapna Desai, Rahul K Gajbhiye, Krina T Zondervan, Vanita Jain, Robyn Norton","doi":"10.25259/IJMR_1338_2025","DOIUrl":"10.25259/IJMR_1338_2025","url":null,"abstract":"<p><p>Background & objectives Endometriosis, a chronic inflammatory condition, affects approximately 10 per cent of reproductive-age women in India. This study aimed to explore the experiences of women with endometriosis and their partners. Methods A qualitative exploratory study was conducted in two Indian States. In-depth interviews were conducted with 21 women (18-49 yr) with laparoscopically diagnosed endometriosis and 10 of their male partners. Interviews were conducted in local languages and English, with informed consent. Recordings were transcribed, coded, and analysed using Braun and Clarke's thematic analysis. Results The study revealed significant impacts of endometriosis on both women and men, including decreased quality of life, psychological effects, financial distress, strained intimate relationships and burden of infertility. Women experienced greater impacts, particularly in life opportunities and employment, social life and mental health. Delayed diagnosis and treatment exacerbated women's suffering, compromising their well-being and quality of life. Interpretation & conclusions This study emphasises the need for improved early diagnosis and treatment of endometriosis to mitigate its impact on women and their partners.</p>","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"162 5","pages":"622-630"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Setting research priorities for cancer in India: Findings from a CHNRI exercise by ICMR & AIIMS-NCI. 为印度癌症设定研究重点:ICMR和AIIMS-NCI的一项CHNRI研究结果。
IF 2.5 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 DOI: 10.25259/IJMR_1246_2025
Jyoti Sharma, Alok Thakar, Goura Kishor Rath, Pramit Ghosh, Prashant Mathur, Jitendra Kumar Meena, Mausumi Bharadwaj, Neelam Shirsat, Nabendu Sekhar Chatterjee, Ajaykiran Shashikiran Chavan, Saritha Shamsunder, Shalini Singh, Sudeep Gupta, Taruna Madan Gupta, Sushma Bhatnagar, Neerja Bhatla, Rupinder Singh Dhaliwal, Tanvir Kaur

Background & objectives With limited funding and vast array of research ideas, setting priorities becomes essential to ensure effective and efficient use of resources. This study aims to systematically identify key research questions in cancer through stakeholder engagement using the Child Health and Nutrition Research Initiative method which is a new concept in the Indian context. Methods The Indian Council of Medical Research held a research priority-setting exercise on May 7-8, 2024 at All India Institute of Medical Sciences-National Cancer Institute, Jhajjar, Haryana, engaging 84 participants across India using CHNRI methodology. Experts were divided into four thematic groups. In Step I, each group proposed research questions, which were scored based on five predefined criteria (answerability, efficacy, relevance, deliverability, equity) and arranged in descending order. In Step II, the highest-scoring questions were further validated through full-house voting. Questions receiving a consensus of more than two-third were finalised as priorities. Results In Step I, 99 questions were generated which covered descriptive (n=10), development (n=65), discovery (n=14), and delivery research (n=10). Development group questions were subcategorised as Technologies (diagnostics/devices/digital) (n=17), Therapeutics (n=16), Prevention and screening (n=20), and Palliative care and survivorship (n=12). During validation (Step II), 36 questions across all domains received >66 per cent scores, resulting in research priorities. Interpretation & conclusions The priority setting exercise helped in short listing research questions in area of cancer in India and provided actionable guidance to policymakers and funders enabling appropriate usage of limited funds.

背景与目标由于有限的资金和大量的研究想法,确定优先事项对于确保有效和高效地利用资源至关重要。本研究旨在通过使用儿童健康和营养研究倡议方法,通过利益相关者的参与,系统地确定癌症的关键研究问题,这是印度背景下的一个新概念。印度医学研究委员会于2024年5月7日至8日在哈里亚纳邦Jhajjar的全印度医学科学研究所-国家癌症研究所举行了一项研究重点设定演习,采用CHNRI方法,共有84名印度参与者参与。专家们分为四个专题小组。在第一步中,每个小组提出研究问题,根据五个预定义的标准(可答性、有效性、相关性、可交付性、公平性)进行评分,并按降序排列。在第二步中,得分最高的问题通过全院投票进一步验证。获得三分之二以上一致意见的问题最终确定为优先事项。在第一步中,产生了99个问题,包括描述性(n=10)、发展性(n=65)、发现性(n=14)和交付性研究(n=10)。发展组的问题被细分为技术(诊断/设备/数字)(n=17)、治疗(n=16)、预防和筛查(n=20)以及姑息治疗和生存(n=12)。在验证(第二步)期间,所有领域的36个问题获得了bbbb66分,从而确定了研究优先级。解释和结论优先事项确定工作有助于将印度癌症领域的研究问题短列出来,并为政策制定者和资助者提供了可操作的指导,使有限的资金能够得到适当的使用。
{"title":"Setting research priorities for cancer in India: Findings from a CHNRI exercise by ICMR & AIIMS-NCI.","authors":"Jyoti Sharma, Alok Thakar, Goura Kishor Rath, Pramit Ghosh, Prashant Mathur, Jitendra Kumar Meena, Mausumi Bharadwaj, Neelam Shirsat, Nabendu Sekhar Chatterjee, Ajaykiran Shashikiran Chavan, Saritha Shamsunder, Shalini Singh, Sudeep Gupta, Taruna Madan Gupta, Sushma Bhatnagar, Neerja Bhatla, Rupinder Singh Dhaliwal, Tanvir Kaur","doi":"10.25259/IJMR_1246_2025","DOIUrl":"10.25259/IJMR_1246_2025","url":null,"abstract":"<p><p>Background & objectives With limited funding and vast array of research ideas, setting priorities becomes essential to ensure effective and efficient use of resources. This study aims to systematically identify key research questions in cancer through stakeholder engagement using the Child Health and Nutrition Research Initiative method which is a new concept in the Indian context. Methods The Indian Council of Medical Research held a research priority-setting exercise on May 7-8, 2024 at All India Institute of Medical Sciences-National Cancer Institute, Jhajjar, Haryana, engaging 84 participants across India using CHNRI methodology. Experts were divided into four thematic groups. In Step I, each group proposed research questions, which were scored based on five predefined criteria (answerability, efficacy, relevance, deliverability, equity) and arranged in descending order. In Step II, the highest-scoring questions were further validated through full-house voting. Questions receiving a consensus of more than two-third were finalised as priorities. Results In Step I, 99 questions were generated which covered descriptive (n=10), development (n=65), discovery (n=14), and delivery research (n=10). Development group questions were subcategorised as Technologies (diagnostics/devices/digital) (n=17), Therapeutics (n=16), Prevention and screening (n=20), and Palliative care and survivorship (n=12). During validation (Step II), 36 questions across all domains received >66 per cent scores, resulting in research priorities. Interpretation & conclusions The priority setting exercise helped in short listing research questions in area of cancer in India and provided actionable guidance to policymakers and funders enabling appropriate usage of limited funds.</p>","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"162 5","pages":"573-580"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The outbreak of amoebic meningoencephalitis in Kerala: A wake-up call. 喀拉拉邦阿米巴脑膜脑炎的爆发:一个警钟。
IF 2.5 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 DOI: 10.25259/IJMR_2975_2025
Sumeeta Khurana
{"title":"The outbreak of amoebic meningoencephalitis in Kerala: A wake-up call.","authors":"Sumeeta Khurana","doi":"10.25259/IJMR_2975_2025","DOIUrl":"10.25259/IJMR_2975_2025","url":null,"abstract":"","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"162 5","pages":"559-562"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826385/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' Response. 作者的回应。
IF 2.5 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 DOI: 10.25259/IJMR_3493_2025
Rajat Kumar Agarwal, Rakesh Dhanya, Lalith Parmar, Amit Sedai, George Mani, Aniruddha Dhar, Santhosh Hegde, Sundar Periyavan, Nagaraj Erappa, Anusha S, Sudha Kumar, Balasubramani Rengaraj, Mamatha G N, Manjunatha N, R N Prasad, Rashmi Fernandes, Adinarayan Makkam, Lawrence Faulkner
{"title":"Authors' Response.","authors":"Rajat Kumar Agarwal, Rakesh Dhanya, Lalith Parmar, Amit Sedai, George Mani, Aniruddha Dhar, Santhosh Hegde, Sundar Periyavan, Nagaraj Erappa, Anusha S, Sudha Kumar, Balasubramani Rengaraj, Mamatha G N, Manjunatha N, R N Prasad, Rashmi Fernandes, Adinarayan Makkam, Lawrence Faulkner","doi":"10.25259/IJMR_3493_2025","DOIUrl":"10.25259/IJMR_3493_2025","url":null,"abstract":"","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"162 5","pages":"710-711"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of tissue diagnosis & its role in cancer care: One year experience from a regional cancer care Institute of Eastern India. 回顾组织诊断及其在癌症护理中的作用:来自东印度地区癌症护理研究所的一年经验。
IF 2.5 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 DOI: 10.25259/IJMR_1460_2025
Sarbashis Hota, Dipkana Das, Srabani Chakrabarti, Debanjan Ghosh, Namrata Maity, Subhajit Hajra, Pronati Gupta, Raya Banerjee

Background & objectives Review of tissue diagnosis is indispensable for any comprehensive tertiary cancer care centre, because a significant bulk of cases are primarily diagnosed peripherally and referred in a hub-and-spoke model. The primary objective of the study was to estimate the proportion of diagnostic discrepancies of the review cases over a period of one year and to identify the probable factors behind these discrepancies. Methods An observational descriptive retrospective cross-sectional study was planned in the department of Laboratory Medicine in a regional cancer institute of Eastern India encompassing all the cases undergoing review (both slides and tissue blocks) in the period between June 2023 and May 2024. Results Total 2551 cases were submitted for review within the study period. Among them 24 caused extreme diagnostic difficulty only because of poor processing. Total 171 cases among 2551 were found to carry significant diagnostic discrepancy (6.7%). A re-biopsy was advised in 69 cases, as essential. Interpretation & conclusions Although many a times the cost of review or the time consumed may pose a problem, a second opinion or a pathologic review is a patient safety mechanism, especially in the setting of cancer.

背景与目的回顾组织诊断是必不可少的任何综合性三级癌症护理中心,因为大量的病例主要是诊断周围和转诊在中心和辐射模型。该研究的主要目的是估计一年内复查病例诊断差异的比例,并确定这些差异背后的可能因素。方法计划在东印度地区癌症研究所检验医学部门进行一项观察性描述性回顾性横断面研究,包括2023年6月至2024年5月期间接受审查的所有病例(包括切片和组织块)。结果研究期间共纳入2551例病例。其中24例仅因处理不当而造成诊断困难。2551例中有171例诊断差异显著(6.7%)。69例建议重新活检,这是必要的。解释与结论虽然很多时候检查的费用或花费的时间可能会造成问题,但第二意见或病理检查是一种患者安全机制,特别是在癌症的情况下。
{"title":"Review of tissue diagnosis & its role in cancer care: One year experience from a regional cancer care Institute of Eastern India.","authors":"Sarbashis Hota, Dipkana Das, Srabani Chakrabarti, Debanjan Ghosh, Namrata Maity, Subhajit Hajra, Pronati Gupta, Raya Banerjee","doi":"10.25259/IJMR_1460_2025","DOIUrl":"10.25259/IJMR_1460_2025","url":null,"abstract":"<p><p>Background & objectives Review of tissue diagnosis is indispensable for any comprehensive tertiary cancer care centre, because a significant bulk of cases are primarily diagnosed peripherally and referred in a hub-and-spoke model. The primary objective of the study was to estimate the proportion of diagnostic discrepancies of the review cases over a period of one year and to identify the probable factors behind these discrepancies. Methods An observational descriptive retrospective cross-sectional study was planned in the department of Laboratory Medicine in a regional cancer institute of Eastern India encompassing all the cases undergoing review (both slides and tissue blocks) in the period between June 2023 and May 2024. Results Total 2551 cases were submitted for review within the study period. Among them 24 caused extreme diagnostic difficulty only because of poor processing. Total 171 cases among 2551 were found to carry significant diagnostic discrepancy (6.7%). A re-biopsy was advised in 69 cases, as essential. Interpretation & conclusions Although many a times the cost of review or the time consumed may pose a problem, a second opinion or a pathologic review is a patient safety mechanism, especially in the setting of cancer.</p>","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"162 5","pages":"689-694"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826387/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aspergillus sensitisation & allergic bronchopulmonary aspergillosis in chronic obstructive pulmonary disease: Redefining a treatable trait. 慢性阻塞性肺疾病的曲霉致敏和过敏性支气管肺曲霉病:重新定义一个可治疗的特征。
IF 2.5 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 DOI: 10.25259/IJMR_2892_2025
Ritesh Agarwal, Inderpaul Singh Sehgal
{"title":"Aspergillus sensitisation & allergic bronchopulmonary aspergillosis in chronic obstructive pulmonary disease: Redefining a treatable trait.","authors":"Ritesh Agarwal, Inderpaul Singh Sehgal","doi":"10.25259/IJMR_2892_2025","DOIUrl":"10.25259/IJMR_2892_2025","url":null,"abstract":"","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"162 5","pages":"555-558"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prioritising mental health research areas for India: A modified delphi-based exercise by the Indian Council of Medical Research. 为印度确定精神健康研究领域的优先次序:印度医学研究理事会基于德尔菲的改进练习。
IF 2.5 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 DOI: 10.25259/IJMR_1262_2025
Neha Dahiya, Ashoo Grover, Vivek Agarwal, Anadrika Debbarma, Priti Arun, Yatan Pal Singh Balhara, Preeti Bajpai, Anant Bhan, Amit Chakrabarti, Basudev Das, Ranita Devi Athokpam, Rupinder Dhaliwal, Smita Deshpande, Sandeep Grover, Johncy James, Amit Khanna, Pulkit Verma, Rajkumar Lenin Singh, Prashant Mishra, Padmavati Ramachandran, Om Prakash, Parveen, Deepshikha Prasad, Neena Sawant, Ravinder Singh, Gunjan Singh

Background & objectives The prevalence of mental health disorders in India is a growing public health concern, yet there is a dearth of initiatives and consensus on prioritising mental health research areas at the national level. This paper presents the findings from the modified Delphi-based exercise undertaken by the Indian Council of Medical Research (ICMR) to address this gap. By engaging key stakeholders from diverse sectors-including mental health professionals, State programme officers, health care providers, policymakers, researchers, and civil society representatives-the exercise aimed to identify critical mental health research gaps and develop a blueprint to guide public mental health research in the country. Methods A comprehensive methodology consisting of four steps was followed, including the initial conceptualisation and desk review, a national level brainstorming meeting, restructuring and finalisation of the questions, and prioritisation process. Results Through a rigorous, iterative process of prioritisation and consensus, the top three mental health research questions were identified. These included (i) implementing suicide prevention interventions in schools and colleges, (ii) integrating mental disorder screening and treatment into non-communicable disease care, and (iii) reducing the treatment gap for mental disorders. Conclusion The outcomes of this exercise shall provide valuable insights for mental health research, policy, and resource allocation strategies at the national level.

背景与目标精神健康障碍在印度的流行是一个日益严重的公共卫生问题,但在国家一级缺乏关于精神卫生研究领域优先次序的倡议和共识。本文介绍了印度医学研究委员会(ICMR)为解决这一差距而进行的基于德尔菲的改进演习的结果。通过让来自不同部门的主要利益攸关方————包括精神卫生专业人员、国家规划官员、卫生保健提供者、政策制定者、研究人员和民间社会代表————参与进来,这项工作旨在确定关键的精神卫生研究差距,并制定指导该国公共精神卫生研究的蓝图。方法采用四步综合方法,包括初步概念化和案头审查、国家层面的头脑风暴会议、问题的重组和最终确定以及优先排序过程。结果通过严格的优先排序和共识迭代过程,确定了三个最重要的心理健康研究问题。这些措施包括:(一)在学校和大学实施预防自杀干预措施,(二)将精神障碍筛查和治疗纳入非传染性疾病护理,以及(三)缩小精神障碍的治疗差距。结论本研究结果将为国家层面的心理健康研究、政策和资源配置策略提供有价值的见解。
{"title":"Prioritising mental health research areas for India: A modified delphi-based exercise by the Indian Council of Medical Research.","authors":"Neha Dahiya, Ashoo Grover, Vivek Agarwal, Anadrika Debbarma, Priti Arun, Yatan Pal Singh Balhara, Preeti Bajpai, Anant Bhan, Amit Chakrabarti, Basudev Das, Ranita Devi Athokpam, Rupinder Dhaliwal, Smita Deshpande, Sandeep Grover, Johncy James, Amit Khanna, Pulkit Verma, Rajkumar Lenin Singh, Prashant Mishra, Padmavati Ramachandran, Om Prakash, Parveen, Deepshikha Prasad, Neena Sawant, Ravinder Singh, Gunjan Singh","doi":"10.25259/IJMR_1262_2025","DOIUrl":"10.25259/IJMR_1262_2025","url":null,"abstract":"<p><p>Background & objectives The prevalence of mental health disorders in India is a growing public health concern, yet there is a dearth of initiatives and consensus on prioritising mental health research areas at the national level. This paper presents the findings from the modified Delphi-based exercise undertaken by the Indian Council of Medical Research (ICMR) to address this gap. By engaging key stakeholders from diverse sectors-including mental health professionals, State programme officers, health care providers, policymakers, researchers, and civil society representatives-the exercise aimed to identify critical mental health research gaps and develop a blueprint to guide public mental health research in the country. Methods A comprehensive methodology consisting of four steps was followed, including the initial conceptualisation and desk review, a national level brainstorming meeting, restructuring and finalisation of the questions, and prioritisation process. Results Through a rigorous, iterative process of prioritisation and consensus, the top three mental health research questions were identified. These included (i) implementing suicide prevention interventions in schools and colleges, (ii) integrating mental disorder screening and treatment into non-communicable disease care, and (iii) reducing the treatment gap for mental disorders. Conclusion The outcomes of this exercise shall provide valuable insights for mental health research, policy, and resource allocation strategies at the national level.</p>","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"162 5","pages":"676-680"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826382/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time to move beyond P value. 是时候超越P值了。
IF 2.5 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 DOI: 10.25259/IJMR_3160_2025
Arushi Yadav, Jogender Kumar
{"title":"Time to move beyond P value.","authors":"Arushi Yadav, Jogender Kumar","doi":"10.25259/IJMR_3160_2025","DOIUrl":"10.25259/IJMR_3160_2025","url":null,"abstract":"","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"162 5","pages":"712-713"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of Brucella melitensis whole cell proteomes for diagnosis of human brucellosis. 人布鲁氏菌全细胞蛋白质组学诊断布鲁氏菌病的比较分析。
IF 2.5 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 DOI: 10.25259/IJMR_325_2025
Sudipta Patra, Chaitanya Tellapragada, Prachi Pathak, M Kameswara Rao, Vandana Eshwara Kalwaje, Duraipandian Thavaselvam, Chiranjay Mukhopadhyay

Background & objectives Brucellosis, an occupational zoonosis, poses notable difficulties in diagnosis because of the need for secure facilities and the risk of exposure when using culture-based methods. Conventional serological tests often suffer from cross-reactivity, highlighting the need for more specific diagnostic markers. The purpose of this study was to understand the differences in whole-cell protein expression of Brucella melitensis isolates from patients with acute and chronic brucellosis and to identify immunodominant proteins that could serve as potential diagnostic markers. Methods The study included 16 blood culture-confirmed patients with acute or chronic brucellosis from a cohort of 185 individuals. Clinical isolates of B. melitensis were subjected to two-dimensional gel electrophoresis (2-DE) and PDQuest software analysis to compare proteomic profiles. Differentially expressed proteins were identified using western blotting with infected human serum samples. Further identification of the protein spots was conducted using Matrix-Assisted Laser Desorption/Ionization - Time-of-flight Mass Spectrometry (MALDI-TOF MS). Results The proteomic analysis of B. melitensis identified an average of 249 protein spots. PDQuest software revealed 65 differentially expressed spots, with 17 of these spots successfully identified via MALDI-TOF MS. Western blot assays demonstrated that human sera containing anti-Brucella antibodies reacted with seven immunodominant protein spots. Among these, the outer membrane porin protein (omp25), aldehyde dehydrogenase, and universal stress protein showed potential for differentiating acute from chronic brucellosis. Interpretation & conclusions The findings indicate that omp25, aldehyde dehydrogenase, and universal stress protein are highly specific to B. melitensis infections and could serve as valuable targets for serodiagnosis.

背景与目的布鲁氏菌病是一种职业性人畜共患病,由于需要安全的设施和使用基于培养的方法时存在暴露风险,因此在诊断方面存在显著困难。传统的血清学检测常常存在交叉反应,因此需要更具体的诊断标记。本研究的目的是了解急性和慢性布鲁氏菌病患者分离的梅利特布鲁氏菌全细胞蛋白表达的差异,并确定可作为潜在诊断标记的免疫优势蛋白。方法:从185例患者中选取16例经血培养证实的急性或慢性布鲁氏菌病患者。采用二维凝胶电泳(2-DE)和PDQuest软件对临床分离的山羊白杆菌进行蛋白质组学分析。用感染的人血清样本进行western blotting鉴定差异表达蛋白。利用基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF MS)对蛋白质斑点进行进一步鉴定。结果通过蛋白质组学分析,平均鉴定出249个蛋白点。PDQuest软件发现了65个差异表达点,其中17个通过MALDI-TOF ms成功鉴定。Western blot检测表明,含有抗布鲁氏菌抗体的人血清与7个免疫优势蛋白点反应。其中,外膜孔蛋白(omp25)、醛脱氢酶和通用应激蛋白显示出区分急性和慢性布鲁氏菌病的潜力。结果表明,omp25、醛脱氢酶和通用应激蛋白对melitensis感染具有高度特异性,可作为有价值的血清诊断靶点。
{"title":"Comparative analysis of Brucella melitensis whole cell proteomes for diagnosis of human brucellosis.","authors":"Sudipta Patra, Chaitanya Tellapragada, Prachi Pathak, M Kameswara Rao, Vandana Eshwara Kalwaje, Duraipandian Thavaselvam, Chiranjay Mukhopadhyay","doi":"10.25259/IJMR_325_2025","DOIUrl":"10.25259/IJMR_325_2025","url":null,"abstract":"<p><p>Background & objectives Brucellosis, an occupational zoonosis, poses notable difficulties in diagnosis because of the need for secure facilities and the risk of exposure when using culture-based methods. Conventional serological tests often suffer from cross-reactivity, highlighting the need for more specific diagnostic markers. The purpose of this study was to understand the differences in whole-cell protein expression of Brucella melitensis isolates from patients with acute and chronic brucellosis and to identify immunodominant proteins that could serve as potential diagnostic markers. Methods The study included 16 blood culture-confirmed patients with acute or chronic brucellosis from a cohort of 185 individuals. Clinical isolates of B. melitensis were subjected to two-dimensional gel electrophoresis (2-DE) and PDQuest software analysis to compare proteomic profiles. Differentially expressed proteins were identified using western blotting with infected human serum samples. Further identification of the protein spots was conducted using Matrix-Assisted Laser Desorption/Ionization - Time-of-flight Mass Spectrometry (MALDI-TOF MS). Results The proteomic analysis of B. melitensis identified an average of 249 protein spots. PDQuest software revealed 65 differentially expressed spots, with 17 of these spots successfully identified via MALDI-TOF MS. Western blot assays demonstrated that human sera containing anti-Brucella antibodies reacted with seven immunodominant protein spots. Among these, the outer membrane porin protein (omp25), aldehyde dehydrogenase, and universal stress protein showed potential for differentiating acute from chronic brucellosis. Interpretation & conclusions The findings indicate that omp25, aldehyde dehydrogenase, and universal stress protein are highly specific to B. melitensis infections and could serve as valuable targets for serodiagnosis.</p>","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"162 5","pages":"644-651"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-effectiveness of BPaL/BPaLM as compared to mixed standard of care bedaquiline containing regimen for MDR/RR-TB. 与含有贝达喹啉的混合护理标准方案相比,BPaL/BPaLM治疗MDR/RR-TB的成本效益。
IF 2.5 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-01 DOI: 10.25259/IJMR_158_2025
Malaisamy Muniyandi, Karikalan Nagarajan, Karthick Chelvanayagam, Kavitha Rajsekar, Kirti Tyagi, Chandrasekaran Padmapriyadarsini

Background & objectives Current options for treating tuberculosis (TB) that is resistant to rifampicin (RR-TB) are limited and available regimens are often lengthy and poorly tolerated. However, following recent evidence from the TB PRACTECAL trial, countries are considering programmatic adoption of six-month, all-oral treatment regimen such as bedaquiline, pretomanid, linezolid (BPaL) and BPaL with moxifloxacin (BPaLM). We conducted an economic evaluation to assess whether the introduction of BPaL/BPaLM regimen under National Tuberculosis Elimination Programme (NTEP) for the treatment of multi-drug resistant (MDR)/RR-TB is a cost-effective strategy. The idea was to estimate the incremental cost incurred from BPaL/BPaLM regimen in comparison with the current mix of standard of care (SoC) regimen. Methods We used an economic model comprising a Markov analysis. The study estimated the incremental costs, life years gained and quality adjusted life years (QALYs) gained by the introduction of BPaL/BPaLM regimen for MDR/RR-TB patients. A scenario analysis for different proportions of shorter and longer SoC regimen compared with BPaL/BPaLM was also done. Cost threshold analysis was done to assess the ideal cost at which the drug BPaL/BPaLM turns into cost-saving. Budget impact analysis was conducted to assess the financial implications of adopting BPaL/BPaLM compared to mix SoC, supporting informed decision-making alongside cost-effectiveness analysis for one year. Results The base case analysis showed the total discounted costs by health system perspective for the BPaL, BPaLM and the current mixed SoC were INR 2515, INR 2644 and INR 2630 million, respectively. The ICER for BPaL was INR -379 which indicates that we have to spend INR 379 less per patient for BPaL than the mixed SoC to gain one QALY. The ICER for BPaLM was INR 37 which indicates that we have to spend INR 37 additionally per patient for BPaLM than the mixed SoC to gain one QALY. Interpretation & conclusions Our findings indicate that BPaL based regimens are likely to be cost-saving and more effective than the current mixed SoC in a range of settings. Countries should consider programmatic uptake of BPaL based regimens to treat MDR/RR-TB.

背景与目的目前治疗利福平耐药结核病(TB)的方案有限,现有方案往往耗时长且耐受性差。然而,根据TB PRACTECAL试验的最新证据,各国正在考虑有计划地采用6个月的全口服治疗方案,如贝达喹啉、普雷托马尼、利奈唑胺(BPaL)和BPaL联合莫西沙星(BPaLM)。我们进行了一项经济评估,以评估在国家结核病消除规划(NTEP)下引入BPaL/BPaLM方案治疗多药耐药(MDR)/ r - tb是否是一种具有成本效益的策略。目的是估计BPaL/BPaLM方案与当前混合标准护理(SoC)方案相比所产生的增量成本。方法采用包含马尔可夫分析的经济模型。该研究估计了引入BPaL/BPaLM方案对MDR/RR-TB患者的增量成本、获得的生命年和质量调整生命年(QALYs)。并对BPaL/BPaLM不同比例的短、长SoC方案进行了情景分析。通过成本阈值分析,评估药物BPaL/BPaLM转化为成本节约的理想成本。进行了预算影响分析,以评估采用BPaL/BPaLM与混合SoC相比的财务影响,支持一年的明智决策和成本效益分析。结果基本案例分析显示,从卫生系统角度来看,BPaL、BPaLM和当前混合SoC的总折扣成本分别为2515、2644和2630亿印度卢比。BPaL的ICER为-379印度卢比,这表明为了获得一个QALY, BPaL的每位患者花费比混合SoC少379印度卢比。BPaLM的ICER为37卢比,这表明我们必须为每位患者额外花费37卢比用于BPaLM,而不是混合SoC以获得一个QALY。我们的研究结果表明,在一系列环境中,基于BPaL的方案可能比目前的混合SoC更节省成本,更有效。各国应考虑有计划地采用基于BPaL的方案来治疗耐多药/耐药结核病。
{"title":"Cost-effectiveness of BPaL/BPaLM as compared to mixed standard of care bedaquiline containing regimen for MDR/RR-TB.","authors":"Malaisamy Muniyandi, Karikalan Nagarajan, Karthick Chelvanayagam, Kavitha Rajsekar, Kirti Tyagi, Chandrasekaran Padmapriyadarsini","doi":"10.25259/IJMR_158_2025","DOIUrl":"10.25259/IJMR_158_2025","url":null,"abstract":"<p><p>Background & objectives Current options for treating tuberculosis (TB) that is resistant to rifampicin (RR-TB) are limited and available regimens are often lengthy and poorly tolerated. However, following recent evidence from the TB PRACTECAL trial, countries are considering programmatic adoption of six-month, all-oral treatment regimen such as bedaquiline, pretomanid, linezolid (BPaL) and BPaL with moxifloxacin (BPaLM). We conducted an economic evaluation to assess whether the introduction of BPaL/BPaLM regimen under National Tuberculosis Elimination Programme (NTEP) for the treatment of multi-drug resistant (MDR)/RR-TB is a cost-effective strategy. The idea was to estimate the incremental cost incurred from BPaL/BPaLM regimen in comparison with the current mix of standard of care (SoC) regimen. Methods We used an economic model comprising a Markov analysis. The study estimated the incremental costs, life years gained and quality adjusted life years (QALYs) gained by the introduction of BPaL/BPaLM regimen for MDR/RR-TB patients. A scenario analysis for different proportions of shorter and longer SoC regimen compared with BPaL/BPaLM was also done. Cost threshold analysis was done to assess the ideal cost at which the drug BPaL/BPaLM turns into cost-saving. Budget impact analysis was conducted to assess the financial implications of adopting BPaL/BPaLM compared to mix SoC, supporting informed decision-making alongside cost-effectiveness analysis for one year. Results The base case analysis showed the total discounted costs by health system perspective for the BPaL, BPaLM and the current mixed SoC were INR 2515, INR 2644 and INR 2630 million, respectively. The ICER for BPaL was INR -379 which indicates that we have to spend INR 379 less per patient for BPaL than the mixed SoC to gain one QALY. The ICER for BPaLM was INR 37 which indicates that we have to spend INR 37 additionally per patient for BPaLM than the mixed SoC to gain one QALY. Interpretation & conclusions Our findings indicate that BPaL based regimens are likely to be cost-saving and more effective than the current mixed SoC in a range of settings. Countries should consider programmatic uptake of BPaL based regimens to treat MDR/RR-TB.</p>","PeriodicalId":13349,"journal":{"name":"Indian Journal of Medical Research","volume":"162 5","pages":"581-591"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12826372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145951768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Medical Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1